Free Trial

Cencora (COR) Competitors

Cencora logo
$243.20 +2.22 (+0.92%)
(As of 11/20/2024 ET)

COR vs. MCK, CAH, HSIC, PDCO, OMI, PETQ, HLF, NUS, COSM, and HWH

Should you be buying Cencora stock or one of its competitors? The main competitors of Cencora include McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO), Owens & Minor (OMI), PetIQ (PETQ), Herbalife (HLF), Nu Skin Enterprises (NUS), Cosmos Health (COSM), and HWH International (HWH).

Cencora vs.

McKesson (NYSE:MCK) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, community ranking, dividends, risk and profitability.

McKesson has a net margin of 0.77% compared to Cencora's net margin of 0.51%. Cencora's return on equity of 266.62% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
McKesson0.77% -207.50% 5.45%
Cencora 0.51%266.62%4.20%

McKesson received 224 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 74.33% of users gave McKesson an outperform vote while only 65.40% of users gave Cencora an outperform vote.

CompanyUnderperformOutperform
McKessonOutperform Votes
967
74.33%
Underperform Votes
334
25.67%
CencoraOutperform Votes
743
65.40%
Underperform Votes
393
34.60%

McKesson has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500.

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
McKesson$308.95B0.26$3.00B$19.3132.17
Cencora$638.56M75.05$1.51B$7.5132.38

In the previous week, McKesson had 8 more articles in the media than Cencora. MarketBeat recorded 28 mentions for McKesson and 20 mentions for Cencora. Cencora's average media sentiment score of 1.17 beat McKesson's score of 0.98 indicating that Cencora is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
McKesson
21 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Cencora
17 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

85.1% of McKesson shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 0.1% of McKesson shares are held by insiders. Comparatively, 15.8% of Cencora shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

McKesson pays an annual dividend of $2.84 per share and has a dividend yield of 0.5%. Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.9%. McKesson pays out 14.7% of its earnings in the form of a dividend. Cencora pays out 29.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. McKesson has increased its dividend for 17 consecutive years and Cencora has increased its dividend for 15 consecutive years.

McKesson presently has a consensus target price of $631.57, indicating a potential upside of 1.65%. Cencora has a consensus target price of $271.20, indicating a potential upside of 11.51%. Given Cencora's higher probable upside, analysts plainly believe Cencora is more favorable than McKesson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
McKesson
0 Sell rating(s)
2 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.94
Cencora
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73

Summary

McKesson beats Cencora on 13 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COR vs. The Competition

MetricCencoraDrugs, proprietaries, & sundries IndustryMedical SectorNYSE Exchange
Market Cap$47.92B$14.33B$5.05B$19.84B
Dividend Yield0.92%1.41%4.97%3.50%
P/E Ratio32.3815.6497.3437.73
Price / Sales75.058.731,218.4218.01
Price / Cash11.1012.3733.5117.90
Price / Book60.9512.915.804.86
Net Income$1.51B$776.81M$119.07M$985.93M
7 Day Performance-0.09%0.82%-1.83%0.45%
1 Month Performance2.82%5.13%-3.64%1.05%
1 Year Performance22.33%9.45%31.62%24.67%

Cencora Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COR
Cencora
4.8659 of 5 stars
$243.20
+0.9%
$271.20
+11.5%
+24.1%$47.92B$638.56M32.3846,000Positive News
MCK
McKesson
4.7828 of 5 stars
$621.29
+0.9%
$631.57
+1.7%
+37.2%$78.15B$308.95B32.1751,000
CAH
Cardinal Health
4.8229 of 5 stars
$120.34
+1.7%
$123.00
+2.2%
+14.3%$28.64B$224.45B23.4148,900
HSIC
Henry Schein
3.4398 of 5 stars
$73.73
-1.5%
$78.89
+7.0%
+7.5%$9.33B$12.34B30.3425,000Insider Trade
PDCO
Patterson Companies
4.8209 of 5 stars
$20.06
-1.7%
$28.30
+41.1%
-37.4%$1.80B$6.57B10.967,600
OMI
Owens & Minor
4.8028 of 5 stars
$11.89
-4.2%
$18.50
+55.6%
-37.4%$956.92M$10.33B0.0013,700
PETQ
PetIQ
1.8302 of 5 stars
$30.98
flat
$29.67
-4.2%
N/A$925.99M$1.10B79.441,933
HLF
Herbalife
4.1247 of 5 stars
$8.42
+8.9%
$9.90
+17.6%
-33.5%$778.11M$5.06B9.909,200
NUS
Nu Skin Enterprises
3.6991 of 5 stars
$7.49
-1.3%
$8.88
+18.5%
-57.3%$377.31M$1.97B0.003,700
COSM
Cosmos Health
1.3169 of 5 stars
$0.72
-2.7%
N/A-35.1%$16.81M$53.38M-0.29123
HWH
HWH International
N/A$0.65
-11.0%
N/AN/A$14.47MN/A0.00N/AGap Down

Related Companies and Tools


This page (NYSE:COR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners